EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies

Dylan Smith, Kassandra Flores, Adenrele Olajide

Marshall Journal of Medicine · 31.01.2023 · 9 (1)

DOI: 10.33470/2379-9536.1387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marshall Journal of Medicine, online erschienen am 31.01.2023. Verfasst von Dylan Smith und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins are the first-line therapy in the management of hyperlipidemia.Unfortunately, patients often stop the drug within the first year due to intolerable myalgias.Despite the removal of the drug, some patients experience myotoxicity, and their myalgia persists.In this case, a 75-year-old female presented with myalgias and an elevated creatine phosphokinase (CPK) level despite discontinuing statin therapy.Antibodies to 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA) were found in this patient; she was diagnosed with a rare form of statin-associated autoimmune myopathy, and she was successfully treated with leflunomide, methotrexate, and physical therapy.

Zitieren

APA

Smith, D., Flores, K., & Olajide, A. (2023). A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies. Marshall Journal of Medicine, 9(1). https://doi.org/10.33470/2379-9536.1387

Vancouver

Smith D, Flores K, Olajide A. A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies. Marshall Journal of Medicine. 2023;9(1). doi:10.33470/2379-9536.1387

BibTeX
@article{Smith2023,
  author = {Smith, Dylan and Flores, Kassandra and Olajide, Adenrele},
  title = {A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies},
  journal = {Marshall Journal of Medicine},
  year = {2023},
  volume = {9},
  number = {1},
  doi = {10.33470/2379-9536.1387}
}
Kostenlos starten →